CoChat
Sign Up
Cited by 308Bariatric Surgery and OutcomesBlood Pressure and Hypertension StudiesMinimally Invasive Surgical Techniques

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)

Open access
Schiavon, Carlos Aurelio, Bersch-Ferreira, Angela Cristine, Santucci, Eliana Vieira, Oliveira, Juliana Dantas, Torreglosa, Camila Ragne, Bueno, Priscila Torres, Frayha, Julia Caldas, Santos, Renato Nakagawa, Damiani, Lucas Petri, Noujaim, Patricia Malvina, Halpern, Helio, Monteiro, Frederico L.J., Cohen, Ricardo Vitor, Uchoa, Carlos H., de Souza, Marcio Gonçalves, Amodeo, Celso, Bortolotto, Luiz, Ikeoka, Dimas, Drager, Luciano F., Cavalcanti, Alexandre Biasi, Berwanger, Otavio·2018·Circulation
DOI 10.1161/circulationaha.117.032130PMC PMC5865494
Open this paper in CoChat — free account

Abstract

Background: Recent research efforts on bariatric surgery have focused on metabolic and diabetes mellitus resolution. Randomized trials designed to assess the impact of bariatric surgery in patients with obesity and hypertension are needed. Methods: In this randomized, single-center, nonblinded trial, we included patients with hypertension (using ≥2 medications at maximum doses or >2 at moderate doses) and a body mass index between 30.0 and 39.9 kg/m 2 . Patients were randomized to Roux-en-Y gastric bypass plus medical therapy or medical therapy alone. The primary end point was reduction of ≥30% of the total number of antihypertensive medications while maintaining systolic and diastolic blood pressure <140 mm Hg and 90 mm Hg, respectively, at 12 months. Results: We included 100 patients (76% female, mean age 43.8±9.2 years, mean body mass index 36.9±2.7 kg/m2), and 96% completed follow-up. Reduction of ≥30% of the total number of antihypertensive medications while maintaining controlled blood pressure occurred in 41 of 49 patients from the gastric bypass group (83.7%) compared with 6 of 47 patients (12.8%) from the control group with a rate ratio of 6.6 (95% confidence interval, 3.1–14.0; P <0.001). Remission of hypertension was present in 25 of 49 (51%) and 22 of 48 (45.8%) patients randomized to gastric bypass, considering office and 24-hour ambulatory blood pressure monitoring, respectively, whereas no patient submitted to medical therapy was free of antihypertensive drugs at 12 months. A post hoc analysis for the primary end point considering the SPRINT (Systolic Blood Pressure Intervention Trial) target reached consistent results, with a rate ratio of 3.8 (95% confidence interval, 1.4–10.6; P =0.005). Eleven patients (22.4%) from the gastric bypass group and none in the control group were able to achieve SPRINT levels without antihypertensives. Waist circumference, body mass index, fasting plasma glucose, glycohemoglobin, low-density lipoprotein cholesterol, triglycerides, high-sensitivity C-reactive protein, and 10-year Framingham risk score were lower in the gastric bypass than in the control group. Conclusions: Bariatric surgery represents an effective strategy for blood pressure control in a broad population of patients with obesity and hypertension. Clinical Trial Registration: URL: https://clinicaltrials.gov . Unique identifier: NCT01784848.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.117.032130

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Eligibility, randomization, and follow-up.
Figure 1. Eligibility, randomization, and follow-up.CC BY · PubMed Central
Figure 2. Primary end point and medication use. The proportion of patients with reduction of the total number of antihypertensive drugs of ≥30% while keeping the office blood pressures levels controlled. A, The P value for comparing proportions of patients with primary end point was performed using the Fisher exact test. B, The distribution of the number of antihypertensive medications used during the study period and patients with uncontrolled blood pressure (Office BP). CI indicates confidence interval.
Figure 2. Primary end point and medication use. The proportion of patients with reduction of the total number of antihypertensive drugs of ≥30% while keeping the office blood pressures levels controlled. A, The P value for comparing proportions of patients with primary end point was performed using the Fisher exact test. B, The distribution of the number of antihypertensive medications used during the study period and patients with uncontrolled blood pressure (Office BP). CI indicates confidence interval.CC BY · PubMed Central
Figure 3. Blood pressure. The mean office blood pressure levels over a 12-month period among patients receiving medical therapy and those who underwent gastric bypass surgery. I bars indicate standard deviation. Mean values in each group are provided below the graphs.
Figure 3. Blood pressure. The mean office blood pressure levels over a 12-month period among patients receiving medical therapy and those who underwent gastric bypass surgery. I bars indicate standard deviation. Mean values in each group are provided below the graphs.CC BY · PubMed Central
Figure 4. Proportion of patients who achieved primary end point (bars graphs) and changes in body weight during 12 months (lines graphs). Proportion of patients with reduction of the total antihypertensive drugs of ≥30% while maintaining the office blood pressure levels controlled (bar graph) and change of body weight (line graph). I bars indicate standard deviation.
Figure 4. Proportion of patients who achieved primary end point (bars graphs) and changes in body weight during 12 months (lines graphs). Proportion of patients with reduction of the total antihypertensive drugs of ≥30% while maintaining the office blood pressure levels controlled (bar graph) and change of body weight (line graph). I bars indicate standard deviation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. Arg Bras Cardiol.2010;95:1–51.
  2. ABESO. Diretrizes Brasileiras de Obesidade. In: ABESO, ed 3rd. Itapevi - SP- Brazil, 2009. http://www.abeso.org.br/pdf/diretrizes_brasileiras_obesidade_2009_2010_1.pdf. Accessed October 24, 2017.

Cited by

Sorted by citations

See all 308

Related

See all

Metadata

Authors
Schiavon, C. A., Bersch-Ferreira, A. C., Santucci, E. V., Oliveira, J. D., Torreglosa, C. R., Bueno, P. T., Frayha, J. C., Santos, R. N., Damiani, L. P., Noujaim, P. M., Halpern, H., Monteiro, F. L. J., Cohen, R. V., Uchoa, C. H., de Souza, M. G., Amodeo, C., Bortolotto, L., Ikeoka, D., Drager, L. F., Cavalcanti, A. B., & Berwanger, O.
Affiliations
  • Research Institute (C.A.S., A.C.B.-F., E.V.S., J.D.O., C.R.T., P.T.B., J.C.F., R.N.F., L.P.D., A.B.C., O.B.)
  • Surgical Center (P.M.N., H.H., F.L.J.M.)
  • Hospital Alemão Oswaldo Cruz (BR)
  • Heart Institute, Hypertension Unit, São Paulo, Brazil (C.H.U., L.B., L.F.D.).
  • Department of Hypertension, Dante Pazzanese Institute of Cardiology, São Paulo, Brazil (M.G.d.S., C.A.).
  • Instituto Dante Pazzanese de Cardiologia (BR)
  • Instituto do Coração - HCFMUSP (BR)
  • Intensive Unit (D.I.), Heart Hospital, São Paulo, Brazil.
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2018-03-13
Volume
137
Issue
11
Pages
1132-1142
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/circulationaha.117.032130
PMC
PMC5865494
OpenAlex
W2770989673
Cited by
308
References
33
Citations by year
2026: 27 · 2025: 37 · 2024: 23 · 2023: 42 · 2022: 25 · 2021: 47 · 2020: 54 · 2019: 29 · 2018: 19
FWCI
29.99
Type
journal article
Language
en
Update notices
correction (2019-09-30)
Open access
Licence
cc-by
Locations
  • Circulation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords
bariatric surgery, Roux-en-Y gastric bypass, obesity, hypertension, antihypertensive medication reduction, hypertension remission, blood pressure control, metabolic surgery, cardiovascular risk factors, body mass index, waist circumference, dyslipidemia, C-reactive protein, Framingham risk score, ambulatory blood pressure monitoring, type 2 diabetes remission
MeSH terms
Adult, Antihypertensive Agents, Blood Pressure, Brazil, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Time Factors, Gastric Bypass, Weight Loss, Body Mass Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review